Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FQ93R
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,299
Award facts
- Contract value 100% obligated
- $15,299.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $15,299.12 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pen injectors. The contract, executed on September 26, 2025, with an ultimate completion date of September 29, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location. This award is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare systems.
The delivery order supports the Defense Health Agency and other federal healthcare systems' pharmaceutical supply requirements. AmerisourceBergen Drug Corp maintains a significant federal contracting presence as a major pharmaceutical distributor, routinely fulfilling competitive awards for specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The company's established relationship with DLA through its prime vendor contract demonstrates its capability to meet federal procurement standards and support military medical supply chain operations. This specific transaction for Zepbound reflects ongoing federal procurement of obesity management medications for eligible beneficiaries within the defense healthcare system.
Quick answers
Who was awarded contract SPE2DB25FQ93R?
SPE2DB25FQ93R was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FQ93R worth?
The government has obligated $15,299 on SPE2DB25FQ93R.
Is contract SPE2DB25FQ93R an order under another contract?
Yes. SPE2DB25FQ93R is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB25FQ93R competed?
The extent of competition for SPE2DB25FQ93R was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award